Allergan Aesthetics has secured FDA approval for Skinvive by Juvéderm for the improvement of neck appearance—specifically neck lines and skin texture. This marks the first and only FDA-cleared hyaluronic acid injectable designed specifically for neck treatment, a clinical gap that has forced practitioners to either use off-label filler or refer neck work elsewhere.
Injectables
Skinvive by Juvéderm Wins FDA Approval for Neck — What's in Your Filler Mix Now
AbbVie's newest indication expands the Juvéderm franchise into a high-complaint zone; implications for your injectable protocol and patient conversation.

1-YEAR MOVE
ABBV
▲11.6%
| Ticker | Company | 1-year change |
|---|---|---|
| ABBV | AbbVie (Allergan Aesthetics) | +11.6% |